Medicago Announces Publication of Phase 3 COVID-19 Vaccine Study Results in New England Journal of Medicine - Business Wire

Medicago today announced the publication of the results from the Phase 3 study of COVIFENZ®, COVID-19 vaccine (plant-based virus-like particles [VLP],

QUEBEC CITY--(BUSINESS WIRE)--Medicago today announced the publication of the results from the Phase 3 study of COVIFENZ®, COVID-19 vaccine (plant-based virus-like particles [VLP], recombinant, adjuv… [+3118 chars]

full article...